Latest:
Breast MRI Offers Sensitive Imaging for High-Risk and Diagnosed Patients
Breast MRI helps doctors detect disease in newly diagnosed and high-risk patients without replacing mammograms, according to an expert.
- About Us
- Advertise / Support
- Editorial Board
- Contact Us
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Contributors
Anne M. Reb
Anne M. Reb Reb is a nurse practitioner who holds a PhD, as well as an assistant professor in the Division of Nursing Research and Education within the Department of Population Sciences at City of Hope, located in Duarte, California.
Latest:
Overcoming Barriers to Emotional and Physical Support in Cancer Care
An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression.
Dr. Masey Ross
Dr. Masey Ross is an associate professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine at Virginia Commonwealth University (VCU), VCU School of Medicine. Ross is also the medical director of Clinical Research Affiliations and the medical director of the Integrative Health Program at VCU Massey Cancer Center.
Latest:
How Biomarker Testing Can Inform Metastatic Breast Cancer Care
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Joshua K. Sabari
Dr. Joshua K. Sabari is the editor in chief of CURE. He also serves as an assistant professor in the Department of Medicine at NYU Grossman School of Medicine and director of High Reliability Organization Initiatives at Perlmutter Cancer Center.
Latest:
Understanding the Importance of Biomarker Testing in Lung Cancer
Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.
Holly Sabo
Holly Sabo, MHA, is an administrative director of Hospital Medicine, Pulmonary, Infectious Disease, and Palliative Care at Lahey Hospital & Medical Center Lahey Hospital & Medical Center.
Latest:
Broken Yet Unbreakable: My Previvor Journey and the Power of Symbolism
Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, and honor my journey with purpose.
Dr. Ritu Salani
Dr. Ritu Salani currently serves as the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and is a board-certified gynecologic oncologist.
Latest:
Empowering Patients and Advocating For Yourself After Cervical Cancer
Dr. Ritu Salani discusses how patients with cervical cancer can advocate for their health and collaborate with their medical team to ensure the best care.
Dr. Lydia Scarfò
Dr. Lydia Scarfò is a physician scientist at the B-cell neoplasia Unit and an assistant professor at Università Vita-Salute San Raffaele, Milano, Italy.
Latest:
Side Effects of BGB-16673 Appear Manageable in Early CLL Study
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
Ryan Scott
Ryan Scott is an Associate Editor of CURE; she joined MJH Life Sciences in 2021. In addition to writing and editing timely news and article coverage, she manages CURE's
Latest:
What to Know: Your Questions Answered After a Breast Cancer Diagnosis
October is Breast Cancer Awareness Month, and CURE is here to address some of the most common questions patients have after a breast cancer diagnosis.